Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?

Area of Science:

• Cardiology
• Nephrology
• Pharmacology

Background:

• Hypertension is a prevalent global health issue affecting approximately one billion individuals.
• Cardiac involvement is a significant complication of hypertension.
• Atrial fibrillation is a common cardiac arrhythmia associated with hypertension.

Purpose of the Study:

• To review cardiac involvement in hypertensive patients.
• To evaluate the potential of antihypertensive treatments in preventing cardiac arrhythmias, specifically atrial fibrillation.
• To explore the role of modern therapeutic approaches in managing hypertensive heart disease.

Main Methods:

• Review of current literature on hypertension and cardiac complications.
• Analysis of the electrical and structural remodeling processes in the hypertensive heart.
• Comparison of different antihypertensive drug classes, including ACE inhibitors, AT1 receptor blockers, calcium channel blockers, beta-blockers, and thiazide-type diuretics.

Main Results:

• Hypertension significantly impacts cardiac structure and function.
• Electrical and structural remodeling in the hypertensive heart contributes to arrhythmia development.
• ACE inhibitors and AT1 receptor blockers show promise in preventing atrial fibrillation compared to other drug classes.
• Effective blood pressure management may reduce the incidence of stroke.

Conclusions:

• Modern antihypertensive therapies, especially ACE inhibitors and AT1 receptor blockers, offer a more efficient option for managing hypertensive heart disease.
• These agents may play a crucial role in preventing atrial fibrillation and reducing stroke incidence in hypertensive patients.
• Targeting the remodeling process in the hypertensive heart is key to mitigating cardiac complications.